Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Regulatory measures are needed to ensure safe production and use of platelet concentrates in Brazil.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Pallister-Killian Syndrome is a complex genetic disorder requiring coordinated care and genetic counseling.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Platelet-derived exosomes offer better regenerative therapy but face challenges in isolation and regulation.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Platelet-rich plasma (PRP) shows no significant benefit for bone and soft-tissue injuries or wound healing, and its effectiveness may improve with customization.

JAK inhibitors might help treat Lichen Planopilaris, but more research is needed.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

EF and PXE not closely related.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

PRP therapy significantly regrows hair and satisfies patients without side effects.

Tislelizumab can cause cutaneous lupus erythematosus.

The new human placental extract may help prevent hair graying and reduce nerve pain from chemotherapy.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

FR-1 reduces skin scarring and promotes healing without harmful effects.